US Patent 9506058 Compositions for treating muscular dystrophy
Patent 9506058 was granted and assigned to Sarepta Therapeutics on November, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9506058 Compositions for treating muscular dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.